Inventor · disambiguated record
Stefan Proniuk
Also filed as: PRONIUK STEFAN
11 granted patents·11 pending applications·8 citations·filing 2014–2025
82Inventor score
Files withCONTEXT BIOPHARMA INC7ARNO THERAPEUTICS INC6ANKH LIFE SCIENCES LTD2ARNO THERAPEUTICS2OHIO STATE INNOVATION FOUNDATION2
Top patents by PatentIndex Score
22 records- 0179US9193757B2Onapristone polymorphic forms and methods of useARNO THERAPEUTICS·Filed 2014·Granted Nov 24, 2015·6 cites·8 claims
- 0273US10308676B2Methods of making onapristone intermediatesCONTEXT BIOPHARMA INC·Filed 2016·Granted Jun 4, 2019·1 cites·14 claims
- 0370US2023157960A1Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 0465US11672762B2Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2020·Granted Jun 13, 2023·0 cites·21 claims
- 0565US2020376004A1Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2019·Application pending·0 cites
- 0664US9138425B2Drug delivery system to increase bioavailabilityPATHEON INC·Filed 2014·Granted Sep 22, 2015·0 cites·20 claims
- 0763US9744156B2Methods and compositions for enhanced transungual delivery of AR-12ARNO THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·1 cites·12 claims
- 0863US2023000795A1Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinationsANKH LIFE SCIENCES LTD·Filed 2022·Application pending·0 cites
- 0962US10039833B2Drug delivery system to increase bioavailabilityOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted Aug 7, 2018·0 cites·28 claims
- 1061US10548905B2Amorphous onapristone compositions and methods of making the sameCONTEXT BIOPHARMA INC·Filed 2016·Granted Feb 4, 2020·0 cites·7 claims
- 1158US2025059193A1Polymorphic and salt forms of (1s,3s)-n1-(5-(pentan-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl) cyclopentane-1,3-diamineKRONOS BIO INC·Filed 2022·Application pending·0 cites
- 1256US10786461B2Onapristone extended-release compositions and methodsCONTEXT BIOPHARMA INC·Filed 2015·Granted Sep 29, 2020·0 cites·16 claims
- 1356US2025186367A1Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinationsANKH LIFE SCIENCES LTD·Filed 2025·Application pending·0 cites
- 1454US11613555B2Methods for onapristone synthesis dehydration and deprotectionCONTEXT BIOPHARMA INC·Filed 2020·Granted Mar 28, 2023·0 cites·22 claims
- 1553US9579387B2Drug delivery system to increase bioavailabilityARNO THERAPEUTICS INC·Filed 2015·Granted Feb 28, 2017·0 cites·20 claims
- 1649US2014271604A1HDAC Inhibitor Polymorphic Forms and Methods of UsePRONIUK STEFAN·Filed 2014·Application pending·0 cites
- 1748US2018148471A1Methods for onapristone synthesis dehydration and deprotectionARNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1838US2017266204A1Onapristone metabolite compositions and methodsARNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1935US9974771B2Compositions and methods for reducing prion levelsOHIO STATE INNOVATION FOUNDATION·Filed 2017·Granted May 22, 2018·0 cites·12 claims
- 2035US2015231155A1Onapristone polymorphic forms and methods of useARNO THERAPEUTICS·Filed 2015·Application pending·0 cites
- 2133US2016199351A1Compositions and methods for inhibiting fungal infectionsARNO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2225US2016213647A1Compositions and methods for inhibiting viral infectionARNO THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Proniuk files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →